NDC 70000-0263-01 - LEADER CHILDRENS IBUPROFEN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70000-0263
- Requested NDC
- 70000-0263-01
- Package NDCs from labels
- 70000-0263-1, 70000-0263-2, 70000-0263-3, 70000-0263-01
- Manufacturer
- Cardinal Health 110, LLC. dba Leader
- Effective date
- 2025-03-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LEADER CHILDRENS IBUPROFEN - Cardinal Health 110, LLC. dba Leader | Cardinal Health 110, LLC. dba Leader | 2025-03-03 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70000-0263-1 | LEADER CHILDRENS IBUPROFEN | 1 in 1 CARTON | SUSPENSION | 1 | 5 | |
| 70000-0263-1 | LEADER CHILDRENS IBUPROFEN | 120 mL in 1 BOTTLE | SUSPENSION | 120 | 5 | |
| 70000-0263-2 | LEADER CHILDRENS IBUPROFEN | 240 mL in 1 BOTTLE | SUSPENSION | 240 | 5 | |
| 70000-0263-2 | LEADER CHILDRENS IBUPROFEN | 1 in 1 CARTON | SUSPENSION | 1 | 5 | |
| 70000-0263-3 | LEADER CHILDRENS IBUPROFEN | 150 mL in 1 BOTTLE | SUSPENSION | 150 | 5 | |
| 70000-0263-3 | LEADER CHILDRENS IBUPROFEN | 1 in 1 CARTON | SUSPENSION | 1 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70000-0263 | LEADER CHILDRENS IBUPROFEN (IBUPROFEN) SUSPENSION [CARDINAL HEALTH 110, LLC. DBA LEADER] | 5 | Current NDC, Legacy NDC, 6 package rows | 20250305_913a4bd0-0784-45b4-b05e-3e7c016bbb86.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70000-0263-1 | ML - Milliliter | 70000-0263 | fbb179f2-5d83-4b39-a4c8-7f816a8d06e2 | 1 | 2017-11-06 |
| 70000-0263-2 | ML - Milliliter | 70000-0263 | fbe88e6f-ef78-4794-b3b0-585c7211eea8 | 1 | 2017-11-06 |
| 70000-0263-3 | ML - Milliliter | 70000-0263 | 5146b58d-9db9-4309-b673-3ed748b15b86 | 1 | 2018-03-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ibuprofen | IBUPROFEN | Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd | 58bff8bf-5a4e-4390-9c03-e266d31deb6b | 2019-11-22 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd | daf579dc-91d1-4950-b637-c1a34f5542c5 | 2019-11-22 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Sam's West, Inc. | 90c301ad-7bbd-4e21-8054-35596b208cd4 | 2019-11-21 | Warnings | WK2XYI10QM |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | e41adb4e-06fb-4141-ba55-50b043f3c9da | 2019-11-19 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 14445dfd-6041-40cd-a043-3f4da6bcb9c1 | 2019-11-18 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 2557199a-5f60-49d8-b093-1e0700211243 | 2019-11-18 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 794f724c-87f0-49c1-9b26-c9e491978313 | 2019-11-18 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 5c7d3287-883a-459b-9214-074a583c8a59 | 2019-11-18 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 448a1dc5-7a98-4b2f-82af-4b92de05cfc3 | 2019-11-18 | XF417D3PSL | |
| Ibuprofen | IBUPROFEN | Proficient Rx LP | 72b32512-05c7-4113-b0cc-de9c97de2abb | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | 197803 WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Bionpharma Inc. | d7d00fe3-c537-486e-8156-9b56b550bff5 | 2019-09-06 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Wal-Mart Stores, Inc | c100129d-3754-4d0e-b754-76440d55944a | 2019-08-23 | Warnings | WK2XYI10QM |
| Ibuprofen 200 | IBUPROFEN | WALGREEN COMPANY | 5fe0bdfa-1d5b-4657-a32b-f531b69bac0d | 2019-08-13 | Warnings | WK2XYI10QM |
| IBU | IBUPROFEN | Aphena Pharma Solutions - Tennessee, LLC | ffec2f44-1144-4729-b43a-1db40ea6a8d3 | 2019-05-15 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen mini | IBUPROFEN MINI | Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd | 787cda64-c03e-462e-9590-6f04b6860610 | 2019-05-02 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | CHAIN DRUG MARKETING ASSOCIATION INC | b234d42e-1333-48a1-8565-35d9759e8085 | 2019-03-29 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Topco Associates LLC | 4aef9935-2e36-4779-a8a8-5288060573af | 2019-03-08 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Aphena Pharma Solutions - Tennessee, LLC | 4a86a190-da5d-4b7a-a05f-e3e7ccbfa603 | 2019-01-19 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen 200mg | IBUPROFEN 200MG | Allegiant Health | 51e95588-39af-40d6-9924-e98d42af15b9 | 2018-12-31 | Warnings | WK2XYI10QM |
| Dynamic Eyewash with Eyecup | WATER | Dynamic Safety International | 7d3af0f4-0e1f-9ea5-e053-2991aa0af7a2 | 2018-12-17 | Warnings | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.